Skeletal muscle myosin binding protein c in fatigue and aging
NCT ID NCT05926219
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2017
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults between the ages 18-35 or 65-80 years * Healthy by self-report * Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring * Fluent in English (due to lack of translation services, it is not practical to conduct the study using a language other than English). Exclusion Criteria: * Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.). * Volunteer has dementia or related mental issues that potentially put the subject at risk as determined by prior diagnosis. * Volunteer has known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease or Cushing's syndrome, etc.) * Volunteer has untreated/poorly-controlled hypertension (stage 2, per American College of Cardiology \[\>140/90 mmHg\]). * Volunteer has significant heart, liver, kidney or respiratory disease. * Volunteer has diabetes (insulin dependent or non-insulin dependent). * Volunteer has known coagulopathies. * Volunteer has taken anabolic steroids in the prior six months. * Volunteer has received treatment for cancer (other than effective Mohs Surgery for successful removal of basal cell or squamous cell carcinomas) * Unexpected weight loss \>5kg is last 12 months * Volunteer is an active smoker or quit within the last year. * Volunteer has known current alcohol or drug use disorder (AUD; defined as binge drinking of \>4 days in the last month. Binge drinking is \>5 drinks for men and \>4 drinks for women, per occasion). Or, if a volunteer reports drinking in excess of "low risk" per NIAAA (\>7 drinks/week for men and \>3 drinks/day for women and \>14 drinks/week and \>4 drinks/day). * Volunteer has a diagnosed neuromuscular disorder. * Volunteer has allergy to lidocaine.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Oregon
RECRUITINGEugene, Oregon, 97403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A multi-center, randomized, double-blind, placebo-controlled, phase 1/2 clinical trial to evaluate the efficacy and safety of EN001 in patients with sarcopenia
- Longevity metrics AI/ML development study: a standing data library and Model-Development platform for predicting and validating health measurements, longevity, and disease
- A simple pudding might help fight muscle loss in seniors
- Can exercise counteract Cancer's muscle wasting?
- Hidden muscle loss in Sjögren's syndrome: a new study looks for answers
- Can Weight-Loss surgery weaken protein digestion in older adults?